In fight with epidemic, which has overtaken nearly all measures to contain this, researchers turn round in strategies in same antiretroviral medicine (ARV), which is used successfully to address HIV in hope they will as efficient stronghold for prevention of the virus. For womans, who nearly half of the creation 33 million people, with HIV/FACILITY worldwide, ARV tenofovir has a concrete promise since can be worded as or spoken tablet or vaginal gel, which it is necessary be used daily. But basing methods of the prevention ARV - not without scientific and practical problems. The Network of the Test Microbicide () unadulterated in amongst urgent these problems in the first clinical test to compare directly the tablet and vaginal wordings helium tenofovir.
Partly since determined cells in vagina - a light purposes for virus, women are more, than twice in the same way probably as their male partner to gain HIV through sexual intercourse. As such, clinical analysis, the known as MTN-001, quest to understand as each wording tenofovir work in these infection-prone cell, information, which will help the researcher to define the optimum doses, which it is necessary to reach the concentrations a medicine most likely, to prevent HIV in woman.
MTN-001 also looks to understand to factors, which affect the preferences of the women for one daily method on others since not even best method will be efficient if women do not use this.
MTN-001 - an analysis of the Phase II designed to value the adherence of the women on and acceptance three daily modes tenofovir - tenofovir gel, tenofovir disoproxil fumarate tablets and two together - and pharmacokinetics, or as medicine is absorbed and wide-spread in body by time, each mode. The Analysis enrolled 144 sexual active negative womens HIV-for which all three modes, each during poles week with one between when no product of the analysis is not used. In United Staff, the West Reserve University of the Event in Cleveland and University Pittsburgh now begin to fence the potential participant.
The Additional places, including in South Africa and Uganda, also in analysis, which National Institute of the Allergies and Infectious Diseases, component USA. The National Institutes of Health. The Researchers expect that terminate;complete analysis in 2009.
“Capable be seized in one analysis, and in all woman, information on observance, acceptability, and pharmacokinetics will help us to answer the critical questions about three modes more effectively and with big confidence than we could in separate study. We shall be capable more clear distinguish the differences between each wording, including on cellular level and get to put it more exactly reading in preferences of the women and sample of the adherence,” said Craig W. Hendrix, M.D., associate professor medicine, Fission to Clinical Pharmacology, University School John Hopkins Medicine in Baltimore, Maryland, who, as pulpit of the protocol MTN-001, leads much-site analysis.
In its form of the tablet, tenofovir disoproxil fumarate, heard by name of the mark Viread, - a stronghold one of most broadly used mode for payment HIV. The Active component in tenofovir belongs to the class ARVs named nucleotide transcriptase inhibitors (NRTIs), what action against HIV targetting key enzyme virus it is necessary to do the copy of its genetic material - an essential step for virus to multiply and infect other cells. Tenofovir is Valued in clinical test to be defined if this operative processing can also prevent HIV when is used each day by people, which - a negative HIV-, method heard as preventive maintenance pre- opening, or PrEP. Since vaginal gel, tenofovir - amongst new class of the candidate microbicides with specific activity against HIV. Microbicides - a substances designed to prevent or reduce the sexual transfer HIV when is attached currently in guts vagina or rectum.
In MTN-001, the researchers will value the adherence of the women in each three tenofovir mode through structured interview and questionnaires. The Questions will be focused on their total experience, used mode of the product, prescribing as sexual activity can change, as well mode was be held and why product not was always used - they forgot, is disliked to use the product or give the tablet or gel to other people? Little participants from each site will also take part in deep interview at the end 21- week analysis so researchers can collect more detailed information, including about observance women in and preferences between spoken and vaginal wording and between single and double use mode.
The Researchers will conduct pharmacokinetic studies of the blood plasma ( the fluid component shelters), white blood cells, vaginal fabrics and cells taken from in vagina. For instance, in each average analysis of the period, participants will provide the small amount shelters, which will is used to define how much tenofovir circulates on shelters. On places with laboratory possibility, the blood will also is used to be defined if tenofovir is present in blood cell and if so, independently medicine - in its active or inactive condition. Such studies important since tenofovir not efficient against HIV unless it is actuated by addition two molecules named phosphates, much like lamp can is only included if she has both light bulb and key.
At the end of each period of the analysis, the participants watches for their fixed cut in clinic, and similar tests will are organized as blood so and vaginal liquid. 48 Womans enrolled on two places USA will are enclosed in more intensive estimations of each method whereby researchers will look at blood and sample fabrics in the other length of time after taking medicine.
“Information collected in these intensive study, plus information from the other test, will help us to form the scene, showing attitude between blood level medicine and amount activate medicine in target cell HIV vaginal fabrics. This can be possible to define the concentration a medicine in vaginal cell with simple blood test, then extrapolate the necessary dose a medicine to reach the target concentration for prevention HIV,” explained Dr. Hendrix.
MTN-001 - a part of briefcase of the test, valuing spoken and the forms helium tenofovir. Recently, researchers started first test in pregnant women, looking for to understand extent that pregnancy influences upon as body absorbs the active medicine in helium and can medicine to be sent in fetus. THE SPEECH Analysis (Vaginal and Spoken Interference to Control the Epidemic), test, including 4,300 womans, who is expected that will begin early 2009, will be a first test to efficiency, valuing in the same analysis as microbicide (tenofovir gel) so and PrEP (spoken tenofovir and spoken Truvada, combination tenofovir disoproxil fumarate and other antiretroviral agent was named emtricitabine).
As spoken so and vaginal wordings helium tenofovir were designed Science Gilead, Inc., Receiving City, Californium, USA, which fixed the free license from royalty for thematic helium in International Partnership for Microbicides silver Springtimes, Maryland, and CONRAD, Arlington, Virginia, in December 2006. For MTN-001, Gilead provides tenofovir tablets gratis, and CONRAD provides both gel and applicators helium gratis.
Other microbicide products were or are currently tested in clinical test though nothing until it is approved or available woman for use.
The Network of the Test Microbicide is HIV/network of the clinical test the FACILITIES was fixed in 2006 Fissions of the FACILITIES, National Institute to Allergies and Infectious Diseases, a part USA. The National Institutes of Health (NIH). Brings together international investigators, public and industrial partner, which is dedicated to reduction of the sexual transfer HIV through development and estimation microbicides, laying within unique infrastructure specifically designed to relieve the study been needed to support licensure thematic microbicide products for broadly wide-spread use. Founded in University Pittsburgh and Research Institute Magee-Womens, main investigator - Sharon Hilly, Ph.D. THE MAIN operation is supported network laboratory in University Pittsburgh, statistical and the centre of the management given located within Statistical Centre for HIV/Studies of the FACILITIES & Preventions in Cancerous Research Centre Freda Hutchinson, and Household Health International, global organization with expert operation, conducting clinical protocols. This gets their own funding with three institutes NIH: NIAID, National Institute of Mental Health and National Institute YUnisa Kennedy Shriver Health Child and Human Development.